Medical Technology with YOU at the center
Investor Information
At Odigent, we develop advanced wearable technologies designed to enhance comfort, sensory stability, and functional performance in everyday life. Through precision material engineering and structured environmental modulation, our platform supports the body’s natural resilience in dynamic conditions. We focus on practical, non-invasive solutions that improve usability, adaptability, and long-term performance across diverse populations.
​
Share Price: $1.50
Shares Offered: 1,000,000
Share Class: Common
Download Private Placement Memorandum for more information on Offering.
Our Mission
To empower clinicians and patients with intelligent tools that improve outcomes, and save lives.
Access Investor Materials
Qualified investors may request access to our offering materials, including our Private Placement Memorandum (PPM) and executive briefing documents.
Download Private Placement Memorandum
For secure access to additional investor information, please contact:
📧 info@odigent.com
Why Invest in Odigent
-
AI-powered diagnostic platform (Radilect AI)
-
Next-generation medical devices for early cancer detection
-
Strong regulatory foundation (FDA 510(k), ISO 13485)
-
Mission-driven leadership team
-
Scalable commercial roadmap across clinical and research markets
Innovation & Focus Areas
-
AI diagnostic workflows and radiology automation
-
Medical device development for cancer screening & cell sampling
-
Data-driven clinical insights
-
Precision medicine research and early-stage detection technologies
Legal and Compliance Notice
This page is for informational purposes only and does not constitute an offer to sell or a solicitation to purchase securities. Any securities offering is made only through official offering documents to qualified investors, in accordance with applicable securities laws and regulations.
Past performance is not indicative of future results. Investing in early-stage ventures involves substantial risk, including the potential loss of investment.
✅ Investor FAQ
What is Odigent?
Odigent is a medical technology company focused on AI-powered diagnostics and precision medical devices.
Who can invest?
Accredited investors and qualified institutions under Regulation D.
How do I access the PPM and offering documents?
Request secure access via the form below or contact info@odigent.com.
What stage is Odigent in?
Pre-commercial growth, with R&D, regulatory preparation, and technology development underway.
Is this a solicitation or guarantee?
No. This is informational only. Full details are provided in the official offering documents to qualified investors.
Investor Verification & Confidentiality
To proceed, you acknowledge that:
-
You are an accredited investor or operating on behalf of a qualified entity
-
You will not redistribute or share offering documents without written authorization
-
You understand this does not constitute an offer to sell securities
Click to continue and view confidential investor materials.
Download Investor Overview
​
Legal Disclaimer
This webpage and any linked materials are for informational purposes only and do not constitute an offer to sell or a solicitation to buy securities. Any securities offering will be made only to qualified investors through official offering documents and in compliance with applicable securities laws. Past results do not guarantee future performance. Investing in early-stage companies involves significant risk, including the possible loss of capital.
Get on the List
Sign up to receive the first word when we go live.
